Skip to main content

Advertisement

SpringerLink
Log in

Clinical Determinants of Incremental Shuttle Walk Test in Adults with Bronchiectasis

  • PULMONARY REHABILITATION
  • Published:
Lung Aims and scope Submit manuscript

Abstract

Introduction

Exercise capacity is impaired in patients with bronchiectasis. Incremental shuttle walk test (ISWT) stresses cardiorespiratory system physiologically to symptom-limited maximal exercise capacity. The purpose of this study was to investigate the clinical determinants of ISWT in adults with non-cystic fibrosis (CF) bronchiectasis.

Methods

Forty-one clinically stable bronchiectasis patients aged 18–72 years (27 females, 14 males) participated in the study. Subjects’ demographics and physical characteristics were recorded. Bronchiectasis Severity Index was used to identify disease severity. Pulmonary function test was performed. Dyspnea perception was assessed using the modified Medical Research Council Dyspnea Scale. Maximum inspiratory and expiratory pressures were measured. Peripheral muscle strength using a hand held dynamometer was measured. ISWT was performed to determine exercise capacity. Fatigue Severity Scale, Hospital Anxiety and Depression Scale, Leicester Cough Questionnaire were used to determine fatigue, psychosocial status, and quality of life.

Results

Patients’ mean ISWT distance was 469.5 m. The ISWT distance was significantly related with age (r = − 0.472), height (r = 0.469), gender (r = 0.520), FEV1 (r = 0.651), and FVC (r = 0.545, p < 0.05). Quadriceps muscle strength was higher in males (p = 0.001) as compared to females. Age and gender were identified as independent predictors of the ISWT, explaining 42% of variance in ISWT distance (r = 0.649, r2 = 0.421, F(2,38) = 13.794, p < 0.001).

Conclusion

The clinical determinants of ISWT in clinically stable patients with non-CF bronchiectasis are age and gender. Pulmonary function, dyspnea perception, muscle strength, disease severity, fatigue, psychosocial factors, and health-related quality of life seems to have an independent effect on ISWT in this group of patients with bronchiectasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. O’Leary CJ, Wilson CB, Hansell DM et al (2002) Relationship between psychological well-being, and lung health status in patients with bronchiectasis. Respir Med 96:686–692

    Article  PubMed  Google Scholar 

  2. Newall C, Stockley RA, Hill SL (2005) Exercise training and inspiratory muscle training in patients with bronchiectasis. Thorax 60:943–948

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Koulouris NG, Retsou S, Kosmas E et al (2003) Tidal expiratory flow limitation, dyspnea and exercise capacity in patients with bilateral bronchiectasis. Eur Respir J 21:743–748

    Article  CAS  PubMed  Google Scholar 

  4. Probst VS, Hernandes NA, Teixeira DC et al (2012) Reference values for the incremental shuttle walking test. Respir Med 106:243–248

    Article  PubMed  Google Scholar 

  5. Singh SJ, Morgan MD, Hardman AE et al (1994) Comparison of oxygen uptake during a conventional treadmill test and the shuttle-walking test in chronic airflow limitation. Eur Respir J 17:2016–2020

    Google Scholar 

  6. Wilson CB, Jones PW, O’Leary CJ et al (1997) Validation of the St. George’s Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med 156(2 Pt 1):536–541

    Article  CAS  PubMed  Google Scholar 

  7. de Camargo AA, Amaral TS, Rached SZ et al (2014) Incremental shuttle walking test: a reproducible and valid test to evaluate exercise tolerance in adults with non-cystic fibrosis bronchiectasis. Arch Phys Med Rehabil 95:892–899

    Article  PubMed  Google Scholar 

  8. Lee AL, Button BM, Ellis S et al (2009) Clinical determinants of the 6-minute walk test in bronchiectasis. Respir Med 103:780–785

    Article  CAS  PubMed  Google Scholar 

  9. Chalmers JD, Goeminne P, Aliberti S et al (2014) The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med 189:576–585

    Article  PubMed  PubMed Central  Google Scholar 

  10. Laszlo G (2006) Standardization of lung function testing: helpful guidance from the ATS/ERS Task Force. Thorax 61:744–746

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. American Thoracic Society/European Respiratory Society (2002) ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 166:518–624

    Article  Google Scholar 

  12. Black LF, Hyatt RE (1969) Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Med 99:696–702

    CAS  Google Scholar 

  13. Bestall JC, Paul EA, Garrod R et al (1999) Usefulness of the medical research council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54:581–586

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Bohannon RW (1997) Reference values for extremity muscle strength obtained by hand-held dynamometry from adults aged 20 to 79 years. Arch Phys Med Rehabil 78:26–32

    Article  CAS  PubMed  Google Scholar 

  15. Gosselink R, Troosters T, Decramer M (1996) Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 153:976–980

    Article  CAS  PubMed  Google Scholar 

  16. Aydemir O, Guvenir T, Kuey L et al (1997) Hastane Anksiyete ve Depresyon Ölçeği Türkçe formunun geçerlilik ve güvenilirliği. Türk Psikiyatri Dergisi 8:280–287

    Google Scholar 

  17. Armutlu K, Korkmaz NC, Keser I et al (2007) The validity and reliability of the Fatigue Severity Scale in Turkish multiple sclerosis patients. Int J Rehabil Res 30:81–85

    Article  PubMed  Google Scholar 

  18. Birring SS, Prudon B, Carr AJ et al (2003) Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 58:339–343

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Green SB, Salkind NJ (2008) Using SPSS for Windows and Macintosh: analyzing and understanding data, 5th edn. Prentice Hall, Uppersaddle River, NJ

    Google Scholar 

  20. Gonçalves CG, Mesquita R, Hayashi D et al (2015) Does the Incremental Shuttle Walking Test require maximal effort in healthy subjects of different ages? Physiotherapy 101:141–146

    Article  PubMed  Google Scholar 

  21. Woo JS, Derleth C, Stratton JR et al (2006) The influence of age, gender, and training on exercise efficiency. J Am Coll Cardiol 47:1049–1057

    Article  PubMed  Google Scholar 

  22. Callisaya ML, Blizzard L, Schmidt MD et al (2008) Sex modifies the relationship between age and gait: a population-based study of older adults. J Gerontol A 63:165–170

    Article  Google Scholar 

  23. Vendrell M, Garcia J, Olveira C et al (2008) Diagnosis and treatment of bronchiectasis. Arch Bronconeumol 44:624–640

    Article  Google Scholar 

  24. Kosmas EN, Milic-Emili J, Retsou S et al (2009) Exercise testing and exercise limiting factors in patients with bilateral bronchiectasis. Pneumon 22:296–314

    Google Scholar 

  25. Guan WJ, Gao YH, Xu G et al (2015) Six-minute walk test in Chinese adults with clinically stable bronchiectasis: association with clinical indices and determinants. Curr Med Res Opin 31:843–852

    Article  PubMed  Google Scholar 

  26. King PT, Holdsworth SR, Freezer NJ et al (2010) Lung diffusion capacity in adult bronchiectasis: a longitudinal study. Respir Care 55:1686–1692

    PubMed  Google Scholar 

  27. Sheehan RE, Wells AU, Copley SJ et al (2002) A comparison of serial computed tomography and functional change in bronchiectasis. Eur Respir J 20:581–587

    Article  CAS  PubMed  Google Scholar 

  28. Jurgensen SP, Antunes LC, Tanni SE et al (2011) The incremental shuttle walk test in older Brazilian adults. Respiration 81(3):223–228

    Article  PubMed  Google Scholar 

  29. Ozalp O, Inal-Ince D, Calik E et al (2012) Extrapulmonary features of bronchiectasis: muscle function, exercise capacity, fatigue, and health status. Multidscip Respir Med 7:3

    Article  Google Scholar 

  30. Singer J, Yelin EH, Katz PP et al (2011) Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease: impact on exercise capacity and lower extremity function. J Cardiopulm Rehabil Prev 31:111–119

    Article  PubMed  PubMed Central  Google Scholar 

  31. Martinez Garcia MA, Carro ML, Serra PC (2011) Treatment of non-cystic fibrosis bronchiestasis. Arch Bronconeumol 47:599–609

    PubMed  Google Scholar 

  32. Mandal P, Sidhu MK, Donaldson LS et al (2013) Eight-weekly intravenous antibiotics is beneficial in severe bronchiectasis. QJM 106:27–33

    Article  CAS  PubMed  Google Scholar 

  33. Aksamit TR, O’Donnell AE, Barker A et al (2017) Adults patients with bronchiectasis: a first look at the US bronchiectasis research registry. Chest 151:982–992

    Article  PubMed  Google Scholar 

  34. Roberts HR, Wells AU, Milne DG et al (2000) Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax 55:198–204

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Holland AE, Spruit MA, Troosters T et al (2014) An official European Respiratory Society/American Thoracic Society technical standard: field-walking tests in chronic respiratory disease. Eur Respir J 44:1428–1446

    Article  PubMed  Google Scholar 

  36. Riberio LRG, Mesquita RB, Vidotto LS et al (2015) Are 30 minutes of rest between two incremental shuttle walking tests enough for cardiovascular variables and perceived exertion to return to baseline values? Braz J Phys Ther 19:105–113

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Hacettepe University, Samanpazari, 06100, Ankara, Turkey

    Sulenur Yildiz, Deniz Inal-Ince, Ebru Calik-Kutukcu, Naciye Vardar-Yagli, Melda Saglam & Hulya Arikan

  2. Department of Chest Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey

    Lutfi Coplu

Authors
  1. Sulenur Yildiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Deniz Inal-Ince
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ebru Calik-Kutukcu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Naciye Vardar-Yagli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Melda Saglam
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hulya Arikan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lutfi Coplu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sulenur Yildiz.

Ethics declarations

Conflict of interest

None of the authors have any conflict of interest to declare in relation to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yildiz, S., Inal-Ince, D., Calik-Kutukcu, E. et al. Clinical Determinants of Incremental Shuttle Walk Test in Adults with Bronchiectasis. Lung 196, 343–349 (2018). https://doi.org/10.1007/s00408-018-0094-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-018-0094-x

Keywords

Search

Navigation